Europe Vaccines Market Analysis, Development, Opportunities, Future Growth and Business Prospects (2019-2027)
The Europe Vaccines Market is expected to reach US$ 16,291.0 Mn in 2027 from US$ 9,576.2 Mn in 2018. The market is estimated to grow with a CAGR of 5.5% from 2019-2027.
Europe Vaccines Market Introduction
The European vaccines market is seeing an upward trend, propelled by intensified vaccination awareness programs and increased vaccine research and development activities across Europe. Conversely, vaccine hesitancy within the European region is expected to dampen market growth in the coming period.
Vaccination is a critical public health tool, saving lives and enhancing well-being. Take Polio, an infectious disease caused by poliovirus, which can lead to severe muscle weakness. The polio vaccine provides protection by inducing antibody formation in the bloodstream. Due to concerted efforts to promote the polio vaccine, the World Health Organization declared the European Region polio-free in 2002, a landmark achievement.
European nations are cooperating to eliminate infectious diseases such as measles, diphtheria, and pertussis through robust vaccination initiatives. Various vaccination programs, public awareness campaigns, and educational conferences are regularly organized to engage the population. European Immunization Week (EIW), celebrated annually in April, emphasizes the collective benefit of vaccination. The European Centre for Disease Prevention and Control (ECDC) supports WHO/Europe’s EIW campaign, providing scientific backing for vaccination.
Download our Sample PDF Report
@ https://www.businessmarketinsights.com/sample/TIPRE00005750
Europe Vaccines Strategic Insights
Strategic insights for the Europe Vaccines market deliver a data-driven analysis of the market, covering current trends, prominent players, and unique regional factors. These insights offer actionable advice, helping readers stand out by pinpointing unexplored market niches or creating distinctive value propositions. By utilizing data analytics, these insights help industry participants predict market movements. A forward-looking approach is vital for stakeholders to foresee market changes and ensure long-term success. Ultimately, strong strategic insights equip readers to make sound decisions that boost profitability and realize their business goals in the market.
EUROPE VACCINES MARKET – SEGMENTATION
Europe Vaccines Market – By Technology
- Recombinant vaccines
- Conjugate Vaccines
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
EUROPE VACCINES MARKET – By Disease Indication
- DTP (diphtheria, tetanus, and pertussis)
- Influenza
- Hepatitis
- Other Diseases
EUROPE VACCINES MARKET – By Rout of Administration
- Oral
- Injectable
- Other
EUROPE VACCINES MARKET – By Patient Type
- Adults
- Pediatric
EUROPE VACCINES MARKET – By Country
- Germany
- France
- UK
- Italy
- Spain
EUROPE VACCINES MARKET – Companies Mentioned
- PFIZER INC
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Panacea Biotec Limited
- Astellas Pharma Inc.
- NOVAVAX, INC.
- VBI Vaccines Inc
- Bavarian Nordic
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications